Gongwin Biopharm Holdings Co., Ltd. (TPEX:6617)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
100.00
-1.50 (-1.48%)
Apr 2, 2025, 1:30 PM CST

Gongwin Biopharm Holdings Revenue

In the year 2024, Gongwin Biopharm Holdings had annual revenue of 32.04M TWD with 69.39% growth. Gongwin Biopharm Holdings had revenue of 8.92M in the quarter ending December 31, 2024, with 3.19% growth.

Revenue
32.04M
Revenue Growth
+69.39%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
12.66B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202432.04M13.13M69.39%
Dec 31, 202318.92M17.77M1,554.86%
Dec 31, 20221.14M--
Dec 31, 20211.14M310.00K37.21%
Dec 31, 2020833.00K585.00K235.89%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition